These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Is antagonistic pleiotropy ubiquitous in aging biology? Austad SN; Hoffman JM Evol Med Public Health; 2018; 2018(1):287-294. PubMed ID: 30524730 [TBL] [Abstract][Full Text] [Related]
6. Jekyll and Hyde, the p53 protein, pleiotropics antagonisms and the thrifty aged hypothesis of senescence. Zafon C Med Hypotheses; 2007; 68(6):1371-7. PubMed ID: 17166668 [TBL] [Abstract][Full Text] [Related]
7. p53, ROS and senescence in the control of aging. Vigneron A; Vousden KH Aging (Albany NY); 2010 Aug; 2(8):471-4. PubMed ID: 20729567 [TBL] [Abstract][Full Text] [Related]
8. It's all about balance: p53 and aging. Biteau B; Jasper H Aging (Albany NY); 2009 Nov; 1(11):884-6. PubMed ID: 20157572 [No Abstract] [Full Text] [Related]
9. Reassessing the role of p53 in cancer and ageing from an evolutionary perspective. Aranda-Anzaldo A; Dent MA Mech Ageing Dev; 2007 Apr; 128(4):293-302. PubMed ID: 17291568 [TBL] [Abstract][Full Text] [Related]
10. ATM-Chk2-p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiency. Cao L; Kim S; Xiao C; Wang RH; Coumoul X; Wang X; Li WM; Xu XL; De Soto JA; Takai H; Mai S; Elledge SJ; Motoyama N; Deng CX EMBO J; 2006 May; 25(10):2167-77. PubMed ID: 16675955 [TBL] [Abstract][Full Text] [Related]
11. The Williams' legacy: A critical reappraisal of his nine predictions about the evolution of senescence. Gaillard JM; Lemaître JF Evolution; 2017 Dec; 71(12):2768-2785. PubMed ID: 29053173 [TBL] [Abstract][Full Text] [Related]
12. Aging and cancer: the double-edged sword of replicative senescence. Campisi J J Am Geriatr Soc; 1997 Apr; 45(4):482-8. PubMed ID: 9100719 [TBL] [Abstract][Full Text] [Related]
13. p63: a new link between senescence and aging. Keyes WM; Mills AA Cell Cycle; 2006 Feb; 5(3):260-5. PubMed ID: 16434880 [TBL] [Abstract][Full Text] [Related]
14. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. Coppé JP; Patil CK; Rodier F; Sun Y; Muñoz DP; Goldstein J; Nelson PS; Desprez PY; Campisi J PLoS Biol; 2008 Dec; 6(12):2853-68. PubMed ID: 19053174 [TBL] [Abstract][Full Text] [Related]
16. p53 isoforms regulate premature aging in human cells. von Muhlinen N; Horikawa I; Alam F; Isogaya K; Lissa D; Vojtesek B; Lane DP; Harris CC Oncogene; 2018 May; 37(18):2379-2393. PubMed ID: 29429991 [TBL] [Abstract][Full Text] [Related]
17. Reflections on an unsolved problem of biology: the evolution of senescence and death. Clark WR Adv Gerontol; 2004; 14():7-20. PubMed ID: 15559494 [TBL] [Abstract][Full Text] [Related]
18. Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms. Beck J; Turnquist C; Horikawa I; Harris C Carcinogenesis; 2020 Aug; 41(8):1017-1029. PubMed ID: 32619002 [TBL] [Abstract][Full Text] [Related]
19. From cells to organisms: can we learn about aging from cells in culture? Campisi J Exp Gerontol; 2001 Apr; 36(4-6):607-18. PubMed ID: 11295503 [TBL] [Abstract][Full Text] [Related]
20. TAp63: The fountain of youth. Su X; Flores ER Aging (Albany NY); 2009 Oct; 1(10):866-9. PubMed ID: 20157559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]